Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
The Company has completed acquisition of Think Health Diagnostic Private Limited on February 27, 202427-02-2024
27-02-2024
Thyrocare Technologies Ltd - 539871 - Rectification Of Assessment Order Passed By The Navi Mumbai Municipal Corporation, Cess Department''
Rectification order passed by Navi Mumbai Municipal Corporation, Cess Department.23-02-2024
Thyrocare Technologies Ltd - 539871 - Appointment Of Mr. Nitin Chugh As Chief Commercial Officer Of The Company W.E.F. February 22, 2024
Appointment of Chief Commercial Officer23-02-2024
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Earnings call transcript for the quarter and nine months ended December 31, 2023.05-02-2024
Thyrocare Technologies To Acquire Think Health Diagnostics
Thyrocare Technologies announced its acquisition of Chennai-based Think Health Diagnostics to expand its services, including ECG services at home.05-02-2024
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Unaudited Financials Results for the quarter and nine months ended December 31, 2023.03-02-2024
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
In compliance with Regulation 30(6) read with Part A of Schedule III of the Listing Regulations, we wish to inform that the audio recording of earnings conference call for Analysts and Investors held on February 01, 2024, at 6.00 p.m. with respect to the Company's financial results for quarter and nine months ended December 31, 2023, is available on the company's website https://investor.thyrocare.com/financials/quarterly-financial-results/.02-02-2024
Thyrocare Technologies Ltd - 539871 - Appointment Of Mr. Ankit Brijpuriya As Deputy Company Secretary And Deputy Compliance Officer Of The Company W.E.F. February 01, 2024
Appointment of Deputy Company Secretary and Compliance Officer01-02-2024
Thyrocare Technologies Results Earnings Call for Q3FY24
Conference Call with Thyrocare Technologies Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.01-02-2024